Global Listed Private Equity Invesco ETF (PSP)
$10.04 0.01 (0.10%)
20:00 EDT PSP Stock Quote Delayed 30 Minutes
Previous Close $10.04
Market Cap 199.80M
PE Ratio -
Volume (Avg. Vol.) 62,700
Day's Range 9.95 - 10.08
52-Week Range 6.55 - 13.18
Dividend & Yield 1.04 (10.38%)
PSP Stock Predictions, Articles, and Global Listed Private Equity Invesco ETF News
- From InvestorPlace
- From the Web
To gain access to these private equity deals, there are some ways a regular Joe can do it. Here are seven options on how to invest in private equity without being a billionaire.
The S&P 500 is outperforming XLF by a margin of more than 4-to-1. XLF is one of many financial ETFs that weight components by market value, meaning those funds tilt toward the largest financial stocks, but there are other avenues for approaching the sector.
A small number of mutual funds and ETFs has made private equity available to the masses, but most are not likely to outperform SPY in the long run.
Business development companies are a compelling alternative asset class for income investors, because to be structured as a BDC these companies are required to pay out 90% of their earnings in the form of dividends, as is seen with other income-generating asset classes such as real estate investment trusts (REITs).
For those of you seeking really high-yield exchange-traded funds, this article is for you. Finding dividends above 9% is really challenging, because they either involve companies whose stock prices are falling (and therefore yields rise in turn), or they are leveraged ETFs.
Take 10 minutes to learn how these 10 ETFs to buy for 2018 will get your portfolio set to cash in on what is coming for 2018.
Here are ten high-yield ETFs to fatten up your portfolio's dividend cash flows to recoup from Black Friday shopping after Thanksgiving.
CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Voluntary Share Lock-Up, Engagement of Gold Standard Media for Marketing and Consulting Services
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced that certain shareholders have agreed to a voluntary resale restriction period covering 17,840,000 common shares extending the period of time before the shares become free trading to July 15, 2020. According to […]
CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Appoints New Member to Board of Directors
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, on Monday announced the appointment of Dr. Bill Wilkerson, LL.D. (Hon), an 8-time award-winning pioneer in workplace mental health, to its board of directors. In addition, the company reported the resignation of Mr. Joe […]
Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Expands into US Through Acquisition of Leading Ketamine Center
SHRM announces recent acquisition of California-based Ketamine Wellness Clinic of Orange County Inc. CEO calls acquisition major milestone as company accelerates vision of establishing sizable footprint of integrated ketamine clinics Center is recognized leader in ketamine infusion therapy, research and complementary treatment protocols With the announcement of its recent acquisition of the Ketamine Wellness Clinic […]